Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New digital tool aims to catch frailty early in seniors

NCT ID NCT07570628

Knowledge-focused Sponsor: CNGE Conseil Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a digital tool called Fragiclic can help doctors and nurses screen for frailty in patients aged 65 and older during regular check-ups. Frailty increases the risk of falls, hospital stays, and death. The study will track how many patients get screened and whether those screened have fewer unplanned hospitalizations or deaths over 12 months. No extra tasks are required from participants—the tool is used during normal visits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
digital decision support tool (Fragiclic)
What this could lead to
If successful, this could show that using a simple digital tool in routine check-ups helps identify frailty early and may reduce unplanned hospitalizations and deaths in older adults.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. The tool's impact may be small or hard to measure in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 726 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2027

An estimate. Start dates often move.

Expected to finish

Jan 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients aged 65 years older among GP's patients in primary care

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 65 years or older * Patient or trusted person who provided oral non-opposition after receiving full information about the protocol * Managed by the general practitioner if the patient or nurse during the study period. If patients are assessed by a nurse : Patients whose general practitioner is a participating physician in the study Exclusion Criteria: * Patients unable to express non-opposition or without a trusted person available to express non-opposition * Patients whose general practitioner (GP) is not a participating GP in the study * Patients or trusted persons who do not speak French

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frailty at older adults are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Frailty at older adults Geriatric assessment Implementation research Interprofessional collaboration Primary care

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • MSPU Torcy

    Torcy, Rue Charlie-Chaplin, 77200, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.